(S (NP (NN Combination) (NN therapy)) (VP (VBZ has) (VP (VBN shown) (S (VP (TO to) (VP (VB improve) (NP (JJ therapeutic) (NN efficacy)) (PP (IN while) (S (VP (VBG reducing) (NP (NN side) (NNS effects)))))))))) (. .))
(S (ADVP (RB Importantly)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN become) (NP (DT an) (JJ indispensable) (NN strategy)) (S (VP (TO to) (VP (VB overcome) (NP (NN resistance)) (PP (IN in) (NP (NP (NNS antibiotics)) (, ,) (NP (NNS anti-microbials)) (, ,) (CC and) (NP (JJ anti-cancer) (NNS drugs))))))))) (. .))
(S (S (VP (VBG Facing) (NP (JJ enormous) (UCP (NML (JJ chemical) (NN space)) (CC and) (ADJP (JJ unclear))) (NN design) (NNS principles)) (PP (IN for) (NP (NML (JJ small) (HYPH -) (NN molecule)) (NNS combinations))))) (, ,) (NP (DT the) (JJ computational) (NML (NN drug) (HYPH -) (NN combination)) (NN design)) (VP (VBZ has) (RB not) (VP (VBN seen) (NP (JJ generative) (NNS models)) (S (VP (TO to) (VP (VB meet) (NP (PRP$ its) (NN potential)) (S (VP (TO to) (VP (VB accelerate) (NP (NP (NN resistance)) (HYPH -) (SBAR (S (VP (VBG overcoming) (NP (NN drug)) (NP (NN combination) (NN discovery)))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (VP (VBN developed) (NP (DT the) (JJ first) (JJ deep) (JJ generative) (NN model)) (PP (IN for) (NP (NN drug) (NN combination) (NN design))) (, ,) (PP (IN by) (NP (NP (NP (ADJP (RB jointly) (VBG embedding)) (NN graph)) (HYPH -) (VP (VBN structured) (NP (NN domain) (NN knowledge)))) (CC and) (S (ADVP (RB iteratively)) (VP (VBG training) (NP (DT a) (ADJP (NP (NN reinforcement) (NN learning)) (HYPH -) (VBN based)) (ADJP (NP (NN chemical) (NN graph)) (HYPH -) (VBN set)) (NN designer)))))))) (. .))
(S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN developed) (NP (NP (JJ Hierarchical) (NNP Variational) (NNP Graph) (NNP Auto) (HYPH -) (NNP Encoders) (-LRB- -LRB-) (NNP HVGAE) (-RRB- -RRB-)) (ADJP (VBN trained)) (NML (NML (NN end)) (HYPH -) (PP (IN to) (HYPH -) (NP (NN end))))) (S (VP (TO to) (ADVP (RB jointly)) (VP (VB embed) (NP (NML (NML (NN gene) (HYPH -) (NN gene)) (, ,) (NML (NN gene) (HYPH -) (NN disease)) (, ,) (CC and) (NML (NN disease) (HYPH -) (NN disease))) (NNS networks))))))) (. .))
(S (NP (NP (JJ Novel) (JJ attentional)) (VP (VBG pooling))) (VP (VBZ is) (VP (VBN introduced) (ADVP (RB here)) (PP (IN for) (S (VP (VBG learning) (NP (NN disease) (HYPH -) (NNS representations)) (PP (IN from) (NP (NP (VBN associated) (NNS genes) (POS ')) (NNS representations)))))))) (. .))
(S (ADVP (RB Second)) (, ,) (S (VP (VBG targeting) (NP (NNS diseases)) (PP (IN in) (S (VP (VBN learned) (NP (NNS representations))))))) (, ,) (NP (PRP we)) (VP (VP (VBP have) (VP (VBN recast) (NP (DT the) (NML (NN drug) (HYPH -) (NN combination)) (NN design) (NN problem)) (PP (IN as) (NP (ADJP (NP (NN graph)) (HYPH -) (VBN set)) (NN generation))))) (CC and) (VP (VBD developed) (NP (DT a) (JJ deep) (ADJP (NN learning) (HYPH -) (VBN based)) (NN model)) (PP (IN with) (NP (JJ novel) (NNS rewards))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (PP (IN besides) (NP (NN chemical) (NN validity) (NNS rewards))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN introduced) (NP (DT a) (JJ novel) (JJ generative) (JJ adversarial) (NN award)) (, ,) (S (VP (VBG being) (VP (VBN generalized) (S (VP (VBN sliced) (NP (NNP Wasserstein)) (, ,) (PP (IN for) (NP (NP (ADJP (RB chemically) (JJ diverse)) (NNS molecules)) (PP (IN with) (NP (NP (NNS distributions)) (ADJP (JJ similar) (PP (IN to) (NP (VBN known) (NNS drugs))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP have) (ADVP (RB also)) (VP (VBN designed) (NP (NP (DT a) (ADJP (NP (NN network) (NN principle)) (HYPH -) (VBN based)) (NN reward)) (PP (IN for) (NP (NN drug) (NNS combinations)))))) (. .))
(S (NP (NNP Numerical)) (VP (VBZ results) (SBAR (S (VP (VBP indicate) (SBAR (IN that) (S (, ,) (PP (VBN compared) (PP (IN to) (NP (NN graph) (NN embedding) (NNS methods)))) (, ,) (NP (NNP HVGAE)) (VP (VBZ learns) (NP (ADJP (RBR more) (JJ informative) (CC and) (JJ generalizable)) (NN disease) (NNS representations))))))))) (. .))
(S (NP (NP (NN Case) (NNS studies)) (PP (IN on) (NP (CD four) (NNS diseases)))) (VP (VBP show) (SBAR (IN that) (S (NP (ADJP (NN network) (HYPH -) (JJ principled)) (NN drug) (NNS combinations)) (VP (VBP tend) (S (VP (TO to) (VP (VB have) (NP (JJ low) (NN toxicity))))))))) (. .))
(S (NP (DT The) (ADJP (VBN generated) (NN drug)) (NNS combinations)) (ADVP (RB collectively)) (VP (VP (VBP cover) (NP (DT the) (NN disease) (NN module)) (S (ADJP (JJ similar) (PP (IN to) (NP (ADJP (NNP FDA) (HYPH -) (VBN approved)) (NN drug) (NNS combinations)))))) (CC and) (VP (MD could) (ADVP (RB potentially)) (VP (VB suggest) (NP (JJ novel) (NML (NNS systems) (HYPH -) (NN pharmacology)) (NNS strategies))))) (. .))
